---

$13.63

-0.0100 ( -0.07% ) 1.8K

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2024-08-05	Sale	-7064.00	Nath Kabir
2024-08-05	Sale	-161.00	Jenkins Annalisa
2024-05-22	Sale	-6704.00	Malievskaia Ekaterina
2024-05-22	Sale	-6703.00	Goldsmith George Jay
2024-05-13	Sale	-26000.00	McQuade Robert
2024-05-13	Sale	-26000.00	Lonngren Thomas
2024-05-13	Sale	-26000.00	Karydas Daphne
2024-05-13	Sale	-39000.00	Norton David Y
2024-05-13	Sale	-26000.00	McGoldrick Linda
2024-05-13	Sale	-26000.00	Jenkins Annalisa